M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Trobix Bio completes USD 3m Series A funding
Israel-based biotechnology company Trobix Innovation Ltd. has announced the closing of a USD 3 million Series A funding round led by Chartered Opus, the company said.
The funding will be used to advance the company's antimicrobial resistance platform technology and to further the...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search